Internal drainage for interdisciplinary management of anastomotic leakage after pancreaticogastrostomy.


Journal

Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653

Informations de publication

Date de publication:
07 2023
Historique:
received: 25 09 2022
accepted: 13 02 2023
medline: 7 7 2023
pubmed: 7 3 2023
entrez: 6 3 2023
Statut: ppublish

Résumé

Anastomotic leakage and postoperative pancreatic fistula (POPF) may occur after pancreatic head resection, also in the setting of pancreato-gastric reconstruction. For adequate complication management, a variety of non-standardized treatments are available. Still, data on clinical evaluation of endoscopic methods remain scarce. Based on our interdisciplinary experience on endoscopic treatment of retro-gastric fluid collections after left-sided pancreatectomies, we developed an innovative endoscopic concept with internal peri-anastomotic stent placement for patients with anastomotic leakage and/or peri-anastomotic fluid collection. Over the period of 6 years (2015-2020) we retrospectively evaluated 531 patients after pancreatic head resections at the Department of Surgery, Charité-Unversitätsmedizin Berlin. Of these, 403 received reconstruction via pancreatogastrostomy. We identified 110 patients (27.3%) with anastomotic leakage and/or peri-anastomotic fluid collection and could define four treatment groups which received either conservative treatment (C), percutaneous drainage (PD), endoscopic drainage (ED), and/or re-operation (OP). Patients were grouped in a step-up approach for descriptive analyses and in a stratified, decision-based algorithm for comparative analyses. The study's primary endpoints were hospitalization (length of hospital stay) and clinical success (treatment success rate, primary/secondary resolution). We characterized an institutional, post-operative cohort with heterogenous complication management following pancreato-gastric reconstruction. The majority of patients needed interventional treatments (n = 92, 83.6%). Of these, close to one-third (n = 32, 29.1%) were treated with endoscopy-guided, peri-anastomotic pigtail stents for internal drainage as either primary, secondary and/or tertiary treatment modality. Following a decision-based algorithm, we could discriminate superior primary-(77,8% vs 53.7%) and secondary success rates (85.7% vs 68.4%) as well as earlier primary resolutions (11.4 days, 95%CI (5.75-17.13) vs 37.4 days, 95%CI (27.2-47.5)] in patients receiving an endoscopic compared to percutaneous management. This study underscores the importance of endoscopy-guided approaches for adequate treatment of anastomotic leakage and/or peri-anastomotic fluid collections after pancreatoduodenectomy. We herein report a novel, interdisciplinary concept for internal drainage in the setting of pancreato-gastric reconstruction.

Sections du résumé

BACKGROUND
Anastomotic leakage and postoperative pancreatic fistula (POPF) may occur after pancreatic head resection, also in the setting of pancreato-gastric reconstruction. For adequate complication management, a variety of non-standardized treatments are available. Still, data on clinical evaluation of endoscopic methods remain scarce. Based on our interdisciplinary experience on endoscopic treatment of retro-gastric fluid collections after left-sided pancreatectomies, we developed an innovative endoscopic concept with internal peri-anastomotic stent placement for patients with anastomotic leakage and/or peri-anastomotic fluid collection.
METHODS
Over the period of 6 years (2015-2020) we retrospectively evaluated 531 patients after pancreatic head resections at the Department of Surgery, Charité-Unversitätsmedizin Berlin. Of these, 403 received reconstruction via pancreatogastrostomy. We identified 110 patients (27.3%) with anastomotic leakage and/or peri-anastomotic fluid collection and could define four treatment groups which received either conservative treatment (C), percutaneous drainage (PD), endoscopic drainage (ED), and/or re-operation (OP). Patients were grouped in a step-up approach for descriptive analyses and in a stratified, decision-based algorithm for comparative analyses. The study's primary endpoints were hospitalization (length of hospital stay) and clinical success (treatment success rate, primary/secondary resolution).
RESULTS
We characterized an institutional, post-operative cohort with heterogenous complication management following pancreato-gastric reconstruction. The majority of patients needed interventional treatments (n = 92, 83.6%). Of these, close to one-third (n = 32, 29.1%) were treated with endoscopy-guided, peri-anastomotic pigtail stents for internal drainage as either primary, secondary and/or tertiary treatment modality. Following a decision-based algorithm, we could discriminate superior primary-(77,8% vs 53.7%) and secondary success rates (85.7% vs 68.4%) as well as earlier primary resolutions (11.4 days, 95%CI (5.75-17.13) vs 37.4 days, 95%CI (27.2-47.5)] in patients receiving an endoscopic compared to percutaneous management.
CONCLUSION
This study underscores the importance of endoscopy-guided approaches for adequate treatment of anastomotic leakage and/or peri-anastomotic fluid collections after pancreatoduodenectomy. We herein report a novel, interdisciplinary concept for internal drainage in the setting of pancreato-gastric reconstruction.

Identifiants

pubmed: 36879165
doi: 10.1007/s00464-023-09964-1
pii: 10.1007/s00464-023-09964-1
pmc: PMC10322762
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5065-5076

Informations de copyright

© 2023. The Author(s).

Références

Surg Endosc. 2012 Jun;26(6):1710-7
pubmed: 22179480
JAMA Surg. 2017 Jun 1;152(6):548-549
pubmed: 28241218
J Gastrointest Surg. 2011 Nov;15(11):2080-8
pubmed: 21786063
Surg Endosc. 2013 Jul;27(7):2422-7
pubmed: 23361258
Therap Adv Gastroenterol. 2019 Oct 24;12:1756284819884418
pubmed: 31695750
J Am Coll Surg. 2012 Aug;215(2):177-85
pubmed: 22634120
Surg Endosc. 2022 Jun;36(6):3708-3720
pubmed: 35246738
Surgery. 2021 Jun;169(6):1454-1455
pubmed: 33750597
J Am Coll Surg. 2014 Jan;218(1):33-40
pubmed: 24099888
Gastrointest Endosc. 2020 May;91(5):1085-1091.e1
pubmed: 31843369
World J Gastroenterol. 2016 Jul 28;22(28):6456-68
pubmed: 27605881
World J Gastroenterol. 2018 Apr 21;24(15):1666-1678
pubmed: 29686474
Surg Endosc. 2018 May;32(5):2281-2287
pubmed: 29098435
J Am Coll Surg. 2008 Oct;207(4):490-8
pubmed: 18926450
Gastrointest Endosc. 2011 Aug;74(2):418-23
pubmed: 21679939
Gastrointest Endosc. 2019 Feb;89(2):311-319.e1
pubmed: 30179609
HPB (Oxford). 2019 Apr;21(4):434-443
pubmed: 30293867
J Gastrointest Surg. 2019 Mar;23(3):492-502
pubmed: 30187320
JAMA Surg. 2017 Jun 1;152(6):540-548
pubmed: 28241220
Clin Exp Gastroenterol. 2018 Mar 15;11:105-118
pubmed: 29588609
Surgery. 2017 Mar;161(3):584-591
pubmed: 28040257
Gastrointest Endosc. 2012 Dec;76(6):1259-65
pubmed: 23021161
Surg Endosc. 2022 Sep;36(9):6361-6367
pubmed: 34888711
Nat Rev Clin Oncol. 2019 Jan;16(1):11-26
pubmed: 30341417
J Clin Med. 2021 Jun 10;10(12):
pubmed: 34200840

Auteurs

Matthäus Felsenstein (M)

Department of Surgery, CCM | CVK, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 13353, Berlin, Germany. matthaeus.felsenstein@charite.de.
Berlin Institute of Health (BIH), Charité-Universitätsmedizin Berlin, Berlin, Germany. matthaeus.felsenstein@charite.de.

Ann-Christin Amini (AC)

Department of Surgery, CCM | CVK, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 13353, Berlin, Germany.

Sophie Dorfer (S)

Department of Surgery, CCM | CVK, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 13353, Berlin, Germany.

Mengwen Hu (M)

Department of Surgery, CCM | CVK, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 13353, Berlin, Germany.

Ruonan Wang (R)

Department of Surgery, CCM | CVK, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 13353, Berlin, Germany.

Lea Timmermann (L)

Department of Surgery, CCM | CVK, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 13353, Berlin, Germany.

Karl Herbert Hillebrandt (KH)

Department of Surgery, CCM | CVK, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 13353, Berlin, Germany.
Berlin Institute of Health (BIH), Charité-Universitätsmedizin Berlin, Berlin, Germany.

Christian Benzing (C)

Department of Surgery, CCM | CVK, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 13353, Berlin, Germany.

Uli Fehrenbach (U)

Department of Radiology, CCM | CVK, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Uwe Pelzer (U)

Division of Hematology, Oncology and Tumor Immunology, Medical Department, CCM, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Igor Maximillian Sauer (IM)

Department of Surgery, CCM | CVK, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 13353, Berlin, Germany.
Berlin Institute of Health (BIH), Charité-Universitätsmedizin Berlin, Berlin, Germany.

Johann Pratschke (J)

Department of Surgery, CCM | CVK, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 13353, Berlin, Germany.

Christian Jürgensen (C)

Department of Hepatology and Gastroenterology, CCM | CVK, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Thomas Malinka (T)

Department of Surgery, CCM | CVK, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, 13353, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH